Disposition of 75931 shares by Seth Blackley of Evolent Health at 30.2 subject to Rule 16b-3
9EH Stock | EUR 10.70 0.40 3.88% |
Roughly 55% of Evolent Health's stockholders are presently thinking to get in. The analysis of current outlook of investing in Evolent Health suggests that some traders are interested regarding Evolent Health's prospects. The current market sentiment, together with Evolent Health's historical and current headlines, can help investors time the market. In addition, many technical investors use Evolent Health stock news signals to limit their universe of possible portfolio assets.
Evolent Health stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Evolent daily returns and investor perception about the current price of Evolent Health as well as its diversification or hedging effects on your existing portfolios.
Evolent |
Filed transaction by Evolent Health Director, Officer Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
Evolent Health Fundamental Analysis
We analyze Evolent Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evolent Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evolent Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Z Score
Z Score Comparative Analysis
Evolent Health is rated second in z score category among its peers. Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Evolent Health Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Evolent Health stock to make a market-neutral strategy. Peer analysis of Evolent Health could also be used in its relative valuation, which is a method of valuing Evolent Health by comparing valuation metrics with similar companies.
Peers
Evolent Health Related Equities
4LL | Teladoc | 3.92 | ||||
9EH | Evolent Health | 3.88 | ||||
2HE | Healthequity | 1.69 | ||||
COPA | COMPUGROUP MEDSPADR | 0.97 | ||||
1KJ | 10X GENOMICS | 0.56 | ||||
COP | CompuGroup Medical | 0.28 | ||||
3CM | RLX TECH | 0.54 | ||||
COP | Compugroup Medical | 0.64 | ||||
VEE | Veeva Systems | 2.16 | ||||
1XZ | Ping An | 2.60 |
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stocks Directory Find actively traded stocks across global markets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |